Streptococcus thermophilus Ab.340 TZ enhances doxorubicin efficacy in glioblastoma cells by modulating apoptotic and survival pathways
- DOI
- 10.1016/j.crbiot.2026.100366
- Published
- 2026
- Container
- Current Research in Biotechnology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.crbiot.2026.100366,
title = {Streptococcus thermophilus Ab.340 TZ enhances doxorubicin efficacy in glioblastoma cells by modulating apoptotic and survival pathways},
author = {Abbas Asoudeh-Fard and Hosein Fakhri and Farnood Afrakhteh and Mohadeseh Asoudeh-Fard and Mohammad Abbasi and Ahmad Gholami and Mohammad Bagher Nazari and Erfan Yaghoot and Asghar Parsaei},
year = {2026},
journal = {Current Research in Biotechnology},
doi = {10.1016/j.crbiot.2026.100366},
url = {https://doi.org/10.1016/j.crbiot.2026.100366}
}RIS
TY - JOUR TI - Streptococcus thermophilus Ab.340 TZ enhances doxorubicin efficacy in glioblastoma cells by modulating apoptotic and survival pathways AU - Abbas Asoudeh-Fard AU - Hosein Fakhri AU - Farnood Afrakhteh AU - Mohadeseh Asoudeh-Fard AU - Mohammad Abbasi AU - Ahmad Gholami AU - Mohammad Bagher Nazari AU - Erfan Yaghoot AU - Asghar Parsaei PY - 2026 JO - Current Research in Biotechnology DO - 10.1016/j.crbiot.2026.100366 UR - https://doi.org/10.1016/j.crbiot.2026.100366 ER -
APA
Asoudeh-Fard, A., Fakhri, H., Afrakhteh, F., Asoudeh-Fard, M., Abbasi, M., Gholami, A., Nazari, M. B., Yaghoot, E., & Parsaei, A. (2026). Streptococcus thermophilus Ab.340 TZ enhances doxorubicin efficacy in glioblastoma cells by modulating apoptotic and survival pathways. Current Research in Biotechnology. https://doi.org/10.1016/j.crbiot.2026.100366
Source records
- crossref · retrieved 2026-09-26T09:16:16.793Z